Mercury General (NYSE:MCY – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Thursday.
Mercury General Price Performance
Shares of Mercury General stock traded up $0.47 on Thursday, reaching $78.85. 171,981 shares of the stock were exchanged, compared to its average volume of 236,912. The firm’s 50 day moving average is $68.41 and its 200-day moving average is $61.24. Mercury General has a one year low of $36.37 and a one year high of $79.76. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.33 and a current ratio of 0.33. The firm has a market cap of $4.37 billion, a PE ratio of 7.81 and a beta of 0.81.
Mercury General (NYSE:MCY – Get Free Report) last issued its quarterly earnings results on Tuesday, October 29th. The insurance provider reported $2.54 earnings per share for the quarter, topping analysts’ consensus estimates of $1.15 by $1.39. Mercury General had a net margin of 10.18% and a return on equity of 18.04%. The company had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.37 billion. During the same quarter in the prior year, the firm posted $1.14 EPS. As a group, analysts anticipate that Mercury General will post 6.35 EPS for the current fiscal year.
Hedge Funds Weigh In On Mercury General
Mercury General Company Profile
Mercury General Corporation, together with its subsidiaries, engages in writing personal automobile insurance in the United States. The company also writes homeowners, commercial automobile, commercial property, mechanical protection, and umbrella insurance products. Its automobile insurance products include collision, property damage, bodily injury, comprehensive, personal injury protection, underinsured and uninsured motorist, and other hazards; and homeowners insurance products comprise dwelling, liability, personal property, and other coverages.
Featured Articles
- Five stocks we like better than Mercury General
- What is an Earnings Surprise?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is the NASDAQ Stock Exchange?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is a Dividend King?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Mercury General Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mercury General and related companies with MarketBeat.com's FREE daily email newsletter.